{"url_path":"/sec/cupr/10-k/2026/item-6","section_key":"item-6","section_title":"Item 6 DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES**","topic":"sec","document":{"doc_type":"20-F","doc_date":"2026-04-27","source_url":"https://www.sec.gov/Archives/edgar/data/1995704/0001493152-26-019085-index.html","accession_number":"0001493152-26-019085","cik":"0001995704","ticker":"CUPR","issuer_name":"Cuprina Holdings (Cayman) LTD","edgar_url":"https://www.sec.gov/Archives/edgar/data/1995704/0001493152-26-019085-index.html","primary_entity_key":"0001995704","primary_entity_name":"Cuprina Holdings (Cayman) LTD"},"word_count":4149,"has_tables":true,"body_markdown":"**ITEM\n6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES**\n\n \n\n**A.\nDirectors and senior management.**\n\n \n\nSet\nforth below is information concerning our directors, director appointees, and executive officers.\n\n \n\nName \nAge  \nPosition\n\nDavid Quek Yong Qi \n32  \nDirector and Chief Executive Officer\n\nTeo Peng Kwang \n66  \nNon-Executive Director\n\nJimmy Lee Peng Siew \n70  \nNon-Executive Director\n\nChan Tat Jing \n34  \nChief Financial Officer\n\nKoh Pee Keat \n71  \nIndependent Director\n\nIvan Ng \n47  \nIndependent Director\n\nNatasha Kaur Raina \n51  \nIndependent Director\n\n \n\nThe\nbusiness and working experience and areas of responsibility of our Directors and Executive Officers are set out below:\n\n \n\n**Mr.\nDavid Quek Yong Qi**\n\n \n\nMr.\nQuek, is our director and CEO. Mr. Quek joined Cuprina Pte. Ltd., our operating subsidiary in Singapore, in September 2021. Mr. Quek\nis primarily responsible for overseeing our daily operations driving our strategic goals.\n\n \n\nFrom\n2018 to 2019, Mr. Quek held the position of brand manager at ABR Holdings, a Singapore company listed on the Singapore Exchange, or SGX.\nIn this role, he was responsible for executing marketing campaigns across various brands. Subsequently, from 2020 to 2021, he served\nas the business development director at OEL Holdings, another Singapore company listed on the SGX and is in the medical devices industry.\nDuring his tenure at OEL Holdings, Mr. Quek was responsible for expanding the medical device portfolio, managing strategic partnerships\nand overseeing medical device sales. Mr. Quek obtained his Bachelor of Commerce from the University of Western Australia in 2017.\n\n \n\n**Mr.\nTeo Peng Kwang**\n\n \n\nMr.\nTeo Peng Kwang, or Mr. Teo, is our non-executive director. Mr. Teo has over 30 years of development and management experience in the\nproperty and workers accommodation business. He currently serves as an executive director at Centurion Corporation Limited, a Singapore\ncompany listed on the Singapore Exchange Securities Trading Limited. He was the vice president of the Dormitory Association of Singapore\nLimited from July 2015 to July 2021 and previously was the president of the same association from October 2012 to June 2015. He also\nserved as an independent trustee of the board of trustees for the Migrant Workers’ Assistance Fund from November 2014 to July 2020.\nMr. Teo served as a director of Maxi Global Management Pte Ltd, a company which then provided housing services for foreign workers, from\nMarch 2009 to April 2011. He was also a director of Maxfresh Leisure Pte Ltd, a company principally engaged in the rental services of\nfishing boats, from August 2010 to April 2011. Mr. Teo was also a director of Intertrade (S) Enterprise Pte. Ltd., a company principally\nengaged in chemical trading, from January 2006 to July 2007.\n\n \n\nMr.\nTeo has owned and managed various businesses in Singapore including a real estate and construction business. Mr. Teo was a director of\nISO Industry Pte. Ltd. from March 2006 to February 2011, and Maxi Consultancy Pte. Limited from December 2008 to January 2010. Mr. Teo\nwas also a director at Pointbuilt Pte. Limited from May 2008 to February 2011, Serangoon Garden Staff Apartment Pte. Ltd. from March\n2009 to August 2011 and Swissplan Dormitory Management Pte. Ltd. from September 2007 to April 2011.\n\n \n\nMr.\nTeo completed his primary school education in 1972 at River Valley Primary School in Singapore.\n\n \n\n97\n\n \n\n \n\n**Mr.\nJimmy Lee Peng Siew**\n\n \n\nMr.\nJimmy Lee Peng Siew, or Mr. Lee, is our non-executive director. Mr. Lee has over 43 years of experience in architecture. He currently\nserves as a director at Wenul HL Pte. Ltd., a Singapore company principally engaged in the business of real estate development. He also\nserves as a director at Material Resources Solution Pte. Ltd., a Singapore company principally engaged in the business of recycling.\nFrom 1988 to 2022, he served various roles, and eventually ascending to the position of managing and senior partner at Architects Associates,\na firm offering architectural services in Singapore. In addition, Mr. Lee has established himself in the agriculture and aquaculture\nindustries through ownership and involvement in related businesses.\n\n \n\nMr.\nLee completed his Bachelor’s Degree in Architecture from National University of Singapore in 1981.\n\n \n\n**Mr.\nChan Tat Jing**\n\n \n\nMr.\nChan Tat Jing, or Mr. Chan, is the Chief Financial Officer of the Company. Mr. Chan joined Cuprina Pte. Ltd., our operating subsidiary\nin Singapore, in February 2022 and is primarily responsible for overseeing the financial functions, tax and corporate secretarial matters\nof our Group.\n\n \n\nMr.\nChan has approximately 12 years of experience in accounting and finance. From 2013 to 2019, he worked various roles including manager,\nassistant manager, audit supervisor and audit senior at Ernst & Young in Singapore and Malaysia. From 2019 to May 2021, he held the\nposition of audit manager at PKF-CAP LLP, a member firm of the PKF International Limited network. From June 2021 to December 2021, he\nserved as a finance manager at OEL Holdings.\n\n \n\nMr.\nChan obtained his chartered certified accountant qualification and certified accounting technician qualification from the Association\nof Chartered Certified Accountants and Certificated Accounting Technician in June 2013 and June 2011, respectively. Mr. Chan obtained\nhis Bachelor of Science in applied accounting from Oxford Brookes University in June 2012.\n\n \n\n**Mr.\nKoh Pee Keat**\n\n \n\nMr.\nKoh Pee Keat, or Mr. Koh, has been an independent director of the Company since September 30, 2024. Mr. Koh is the chairman of the audit\ncommittee and a member of the nomination committee and compensation committee.\n\n \n\nMr.\nKoh has over 17 years of banking experience in DBS Bank, Singapore in the area of trade finance, international banking, individual banking,\nand enterprise banking and served in various positions from 1982 to 2000. In particular, from 1992 to 1994, he served as the deputy general\nmanager in DBS New York Agency. He joined Luzhou Bio-Chem Technology Limited, a company based in the PRC and listed on the SGX in 2008\nas its director of finance and has been serving as its chief financial officer since 2019. From 2000 to 2002, he served as the senior\nvice president of Bexcom Pte. Ltd., an e-commerce software provider in Singapore, overseeing its operation, finance, and legal matters.\nFrom 2003 to 2007, he served as the senior vice president and chief financial officer of Westcomb Financial Group Limited, a company\nbased in Singapore and listed on the SGX.\n\n \n\nMr.\nKoh obtained his Bachelor of Arts degree in Accounting and Financial Management from the University of Sheffield in 1982.\n\n \n\n**Mr.\nIvan Ng**\n\n \n\nMr.\nIvan Ng, or Mr. Ng, has been an independent director of the Company since September 30, 2024. Mr. Ng is the chairman of the compensation\ncommittee and a member of the nomination committee and the audit committee.\n\n \n\nMr.\nNg has over 15 years of experience in managing companies in the fast-moving consumer goods industry. From July 2004 to June 2012, he\nserved as the APAC business development director at Procter & Gamble, responsible for developing markets and overseeing marketing\nand sales operations in the Asia-Pacific region. From July 2012 to July 2013, he served as the APAC commercial leader at Unilever, responsible\nfor expanding business in the Asia-Pacific region. From July 2015 to July 2019, he served as the APAC business unit general manager at\nJohnson & Johnson responsible for overseeing the financial performance with the APAC business unit. In addition, Mr. Ng owns and\nmanages various businesses in Singapore. He owns and has been serving as a director of NGarde Venture Pte. Ltd., a Singapore company\nin the business of private investments since February 2021, Tivarian Industries Pte. Ltd., a Singapore company in the business of smart\ncity solutions since January 2020 and RaglanArk Merchantry Pte. Ltd. since February 2022.\n\n \n\n98\n\n \n\n \n\nMr.\nNg obtained a Graduate Diploma of Board Directorship from Singapore Management University in 2023. He obtained an Executive Master’s\nDegree of International Negotiation and Policy-Making from the Geneva Graduate Institute in 2018. In addition, he obtained a Bachelor\nof Engineering degree in Mechanical and Aerospace Engineering from Nanyang Technological University in 2004.\n\n \n\n**Ms.\nNatasha Kaur Raina**\n\n \n\nMs.\nNatasha Kaur Raina, or Ms. Raina, has been an independent director of the Company since September 30, 2024. Ms. Raina is the chairman\nof the nomination committee and a member of the compensation committee and audit committee.\n\n \n\nMs.\nRaina has over 25 years of experience working in research universities, hospitals, and private companies, serving various capacities\nand roles. From January 2018 to December 2023, she served as the deputy director of legal and head of research contracts at the Nanyang\nTechnological University and then director of legal and head of contract and industry engagement at the Duke-NUS Medical School of the\nNational University of Singapore, respectively. In both roles, she was primarily responsible for managing a team that worked on negotiating\nacademic and commercial contracts and she led the legal review and approval process in both organizations to streamline research and\ncommercialization of intellectual properties. From October 2014 to December 2017, she served as a legal manager for a clinical trial\ncompany listed on the New York Stock Exchange, Quintiles (now IQVIA), and was responsible for leading the APAC teams in contract drafting\nand negotiation for sponsor contracts as well as site contracts. From 2000 to 2014, Ms. Raina held various roles related to research\nand development as well as associated legal review and contracts review within the Agency for Science and Technology Research (ASTAR)\nin Singapore as well as Monash University in Australia and the University of Malaya in Malaysia. Prior to 2000, Ms. Raina has also worked\nand led the administrative and research functions at hospitals such as Tan Tock Seng Hospital and the National University Hospital in\nSingapore, and the Specialist Women’s Hospital in Malaysia.\n\n \n\nMs.\nRaina obtained an LLB (Hons) degree with a major in Intellectual Property Law, Commercial Law, and Contract Law from Queen Mary and Westfield\nCollege, University of London in 2012. In 1999, she obtained her Master’s Degree in Clinical Embryology from the National University\nof Singapore. In addition, she obtained a Bachelor of Science degree in Genetics and Microbiology from Queen Mary and Westfield College,\nUniversity of London in 1997.\n\n \n\n**Family\nRelationships**\n\n \n\nAs\nat the date of this Annual Report, our Non-Executive Director, Mr. Jimmy Lee Peng Siew, is the father-in-law of our Director and Chief\nExecutive Officer, Mr. David Quek Yong Qi. Save except as disclosed in this sub-section, there are no family relationships among our\ndirectors and executive officers.\n\n \n\n**B.\nCompensation.**\n\n \n\nFor\nso long as we qualify as a foreign private issuer, we are not required to comply with the proxy rules applicable to U.S. domestic companies,\nincluding the requirement applicable to emerging growth companies to disclose the compensation of our executive officers on an individual,\nrather than an aggregate basis. For the years ended December 31, 2023, 2024 and 2025, we paid an aggregate of approximately S$186,684,\nS$276,864, and S$485,147, respectively, in cash to our directors and executive officers as a group. We have not set aside any amount\nto provide pension, retirement or other similar benefits to our executive officers and directors. We have also not made any agreements\nwith our directors or executive officers to provide benefits upon termination of employment.\n\n \n\nOur\nPRC subsidiary, Cuprina (Beijing) Biotechnology Co. Ltd., is required by law to make contributions equal to certain percentage of each\nemployee’s salary for his or her pension insurance, medical insurance, unemployment insurance and other statutory benefits and\nhousing provident fund.\n\n \n\n**Equity\nCompensation Plan Information**\n\n \n\nWe\nhave not adopted any equity compensation plans.\n\n \n\n**C.\nBoard Practices.**\n\n \n\nOur\nBoard of Directors consists of six Directors. A director is not required to hold any shares in our Company to qualify to serve as a director.\nThe Corporate Governance Rules of the Nasdaq generally require that a majority of an issuer’s board of directors must consist of\nindependent directors. Our Board of Directors has determined that each of Koh Pee Keat, Ivan Ng, and Koh Pee Keat is an “independent\ndirector” as defined under the Nasdaq rules\n\n \n\n99\n\n \n\n \n\n**Committees\nof the Board of Directors**\n\n \n\nWe\nhave established an audit committee, a compensation committee and a nominating and corporate governance committee under our Board of\nDirectors. We adopted a charter for each of the three committees. Each committee’s members and functions are described below. A\ncopy of each of our committee charters is posted on our corporate investor relations website at https://www.cuprina.com.sg.\n\n \n\n*Audit\nCommittee*\n\n \n\nMr.\nKoh, Mr. Ng and Ms. Raina are serving on the audit committee, which is chaired by Mr. Koh. Our board of directors has determined that\neach is “independent” for audit committee purposes as that term is defined by the rules of the SEC and the Nasdaq, and that\neach has sufficient knowledge in financial and auditing matters to serve on the audit committee. Our board of directors has designated\nMr. Koh as an “audit committee financial expert,” as defined under the applicable rules of the SEC. The audit committee’s\nresponsibilities include:\n\n \n\n \n●\nappointing,\napproving the compensation of, and assessing the independence of our independent registered public accounting firm;\n\n \n \n \n\n \n●\npre-approving\nauditing and permissible non-audit services, and the terms of such services, to be provided by our independent registered public\naccounting firm;\n\n \n \n \n\n \n●\nreviewing\nthe overall audit plan with our independent registered public accounting firm and members of management responsible for preparing\nour financial statements;\n\n \n \n \n\n \n●\nreviewing\nand discussing with management and our independent registered public accounting firm our annual and quarterly financial statements\nand related disclosures as well as critical accounting policies and practices used by us;\n\n \n \n \n\n \n●\ncoordinating\nthe oversight and reviewing the adequacy of our internal control over financial reporting;\n\n \n \n \n\n \n●\nestablishing\npolicies and procedures for the receipt and retention of accounting-related complaints and concerns; recommending, based upon the\naudit committee’s review and discussions with management and our independent registered public accounting firm, whether our\naudited financial statements shall be included in our Annual Report on Form 20-F;\n\n \n \n \n\n \n●\nmonitoring\nthe integrity of our financial statements and our compliance with legal and regulatory requirements as they relate to our financial\nstatements and accounting matters;\n\n \n \n \n\n \n●\nreviewing\nall related person transactions for potential conflict of interest situations and approving all such transactions; and\n\n \n \n \n\n \n●\nreviewing\nearnings releases\n\n \n\n*Compensation\nCommittee*\n\n \n\nMr.\nKoh, Mr. Ng and Ms. Raina are serving on the compensation committee, which is chaired by Mr. Ng. The compensation committee’s responsibilities\ninclude:\n\n \n\n \n●\nevaluating\nthe performance of our chief executive officer in light of such corporate goals and objectives and based on such evaluation: (i)\nrecommending to the board of directors the cash compensation of our chief executive officer; and (ii) reviewing and approving grants\nand awards to our chief executive officer under equity-based plans;\n\n \n \n \n\n \n●\nreviewing\nand recommending to the board of directors the cash compensation of our other executive officers;\n\n \n\n100\n\n \n\n \n\n \n●\nreviewing\nand establishing our overall management compensation, philosophy and policy;\n\n \n \n \n\n \n●\noverseeing\nand administering our compensation and similar plans;\n\n \n \n \n\n \n●\nreviewing\nand approving the retention or termination of any consulting firm or outside advisor to assist in the evaluation of compensation\nmatters and evaluating and assessing potential and current compensation advisors in accordance with the independence standards identified\nin the applicable Nasdaq rules;\n\n \n \n \n\n \n●\nretaining\nand approving the compensation of any compensation advisors;\n\n \n \n \n\n \n●\nreviewing\nand approving our policies and procedures for the grant of equity-based awards;\n\n \n \n \n\n \n●\nreviewing\nand recommending to the board of directors the compensation of our directors; and\n\n \n \n \n\n \n●\npreparing\nthe compensation committee report required by SEC rules, if and when required.\n\n \n\n*Nomination\nCommittee*\n\n \n\nMr.\nKoh, Mr. Ng and Ms. Raina are serving on the nomination committee, which is chaired by Ms. Raina. The nomination committee’s responsibilities\ninclude:\n\n \n\n \n●\ndeveloping\nand recommending to the board of directors criteria for board and committee membership;\n\n \n \n \n\n \n●\nestablishing\nprocedures for identifying and evaluating board of directors candidates, including nominees recommended by shareholders; and\n\n \n \n \n\n \n●\nreviewing\nthe composition of the board of directors to ensure that it is composed of members containing the appropriate skills and expertise\nto advise us.\n\n \n\nWhile\nwe do not have a formal policy regarding board diversity, our nomination committee and board of directors will consider a broad range\nof factors relating to the qualifications and background of nominees, which may include diversity (not limited to race, gender or national\norigin). Our nomination committee’s and board of directors’ priority in selecting board members is identification of persons\nwho will further the interests of our shareholders through their established record of professional accomplishment, the ability to contribute\npositively to the collaborative culture among board members, knowledge of our business, understanding of the competitive landscape and\nprofessional and personal experience and expertise relevant to our growth strategy.\n\n \n\n**Code\nof Business Conduct and Ethics**\n\n \n\nWe\nadopted a Code of Business Conduct and Ethics that applies to our principal executive officer, principal financial officer, principal\naccounting officer and controller, or persons performing similar functions. The Code of Business Conduct and Ethics is available at our\ncorporate website at https://www.cuprina.com.sg.\n\n \n\n**Duties\nof Directors**\n\n \n\nUnder\nCayman Islands law, our directors owe fiduciary duties to our Company, including a duty to act honestly, in good faith and with a view\nto our best interests. Our directors must also exercise their powers only for a proper purpose. Our directors also have a duty to exercise\nthe care, diligence and skills that a reasonably prudent person would exercise in comparable circumstances. In fulfilling their duty\nof care to us, our directors must ensure compliance with our memorandum and articles of association, as amended and restated from time\nto time. In certain limited exceptional circumstances, our Company has the right to seek damages against any director who breaches a\nduty owed to us.\n\n \n\nOur\nboard of directors has all the powers necessary for managing, and for directing and supervising, our business affairs. The functions\nand powers of our board of directors include, among others:\n\n \n\n \n●\nconvening\nshareholders’ annual general meetings and reporting its work to shareholders at such meetings;\n\n \n \n \n\n \n●\ndeclaring\ndividends and distributions;\n\n \n \n \n\n \n●\nappointing\nofficers and determining the term of office of officers;\n\n \n \n \n\n \n●\nexercising\nthe borrowing powers of our company and mortgaging the property of our company; and\n\n \n \n \n\n \n●\napproving\nthe registering of such transfer of shares in our share register.\n\n \n\n101\n\n \n\n \n\n**Terms\nof Directors and Officers**\n\n \n\nOur\ndirectors are not subject to a term of office and hold office until such time as they are removed from office by ordinary resolution\nor the unanimous written resolution of all shareholders.\n\n \n\nOur\nofficers are elected by and serve at the discretion of our board of directors, and may be removed by our board of directors.\n\n \n\n**Employment\nAgreements with Executive Officers**\n\n \n\nWe\nhave entered into employment agreements with each of our executive officers for a specified time period providing that the agreements\nare terminable for cause at any time. The terms of these agreements are substantially similar to each other. A senior executive officer\nmay terminate his or her employment at any time by 30-day prior written notice. We may terminate the executive officer’s employment\nfor cause, at any time, without advance notice or remuneration, for certain acts of the executive officer, such as conviction or plea\nof guilty to a felony or any crime involving moral turpitude, negligent or dishonest acts to our detriment, or misconduct or a failure\nto perform agreed duties.\n\n \n\nEach\nexecutive officer has agreed to hold in strict confidence and not to use, except for the benefit of our company, any proprietary information,\ntechnical data, trade secrets and know-how of our company or the confidential or proprietary information of any third party, including\nour subsidiaries and our clients, received by our company. Each of these executive officers has also agreed to be bound by noncompetition\nand non-solicitation restrictions during the term of his or her employment and typically for two years following the last date of employment.\n\n \n\nWe\nexpect to enter into indemnification agreements with our directors and executive officers, pursuant to which we will agree to indemnify\nour directors and executive officers against certain liabilities and expenses incurred by such persons in connection with claims made\nby reason of their being such a director or officer.\n\n \n\n**Clawback\nPolicy**\n\n \n\nOur\nboard of directors have adopted a clawback policy (the “Clawback Policy”) permitting the Company to seek the recoupment of\nincentive compensation received by any of the Company’s current and former executive officers (as determined by the board in accordance\nwith Section 10D of the Exchange Act) and such other senior executives/employees who may from time to time be deemed subject to the Clawback\nPolicy by the board (collectively, the “Covered Executives”). The amount to be recovered will be the excess of the incentive\ncompensation paid to the Covered Executive based on the erroneous data over the incentive compensation that would have been paid to the\nCovered Executive had it been based on the restated results, as determined by the board. If the board cannot determine the amount of\nexcess incentive compensation received by the Covered Executive directly from the information in the accounting restatement, then it\nwill make its determination based on a reasonable estimate of the effect of the accounting restatement. For the year ended December 31,\n2024, we have not sought any recoupment of incentive compensation of the Covered Executives.\n\n \n\n**Involvement\nin Certain Legal Proceedings**\n\n \n\nTo\nthe best of our knowledge, none of our directors or executive officers has, during the past 10 years, been involved in any legal proceedings\ndescribed in subparagraph (f) of Item 401 of Regulation S-K.\n\n \n\n**D.\nEmployees.**\n\n \n\nSee\n“Item 4. Information on the Company—B. Business Overview—Employees.”\n\n \n\n**E.\nShare Ownership.**\n\n \n\nThe\nfollowing table sets forth information regarding the beneficial ownership of our Shares as of the date of this Annual Report by our officers,\ndirectors, and 5% or greater beneficial owners of Shares. There is no other person or group of affiliated persons known by us to beneficially\nown more than 5% of our Shares.\n\n \n\nWe\nhave determined beneficial ownership in accordance with the rules of the SEC. These rules generally attribute beneficial ownership of\nsecurities to persons who possess sole or shared voting power or investment power with respect to those securities. The person is also\ndeemed to be a beneficial owner of any security of which that person has a right to acquire beneficial ownership within 60 days. Unless\notherwise indicated, the person identified in this table has sole voting and investment power with respect to all shares shown as beneficially\nowned by him, subject to applicable community property laws.\n\n \n\n102\n\n \n\n \n\n  \n\n**Ordinary Shares**\n\n**Beneficially Owned**\n \n\n  \n\n**Class A**\n\n**Ordinary**\n\n**Shares**\n  \n\n**Class B**\n\n**Ordinary**\n\n**Shares**\n  \n\n**% of**\n\n**Beneficial**\n\n**Ownership****\n  \n\n**% of**\n\n**Aggregate**\n\n**Voting**\n\n**Power****\n \n\nDirectors and Executive Officers*: \n    \n    \n    \n   \n\nMr. Quek(1) \n -  \n -  \n 14.6  \n 21.0 \n\nMr. Chan \n -  \n -  \n -  \n - \n\nMr. Teo(2) \n -  \n -  \n 27.1  \n 39.3 \n\nMr. Lee(3) \n -  \n -  \n 24.0  \n 34.7 \n\nMr. Koh \n -  \n -  \n -  \n - \n\nMr. Ng \n -  \n -  \n -  \n - \n\nMs. Raina \n -  \n -  \n -  \n - \n\nAll directors and executive officers as a group \n -  \n -  \n 65.7  \n 95.0 \n\n  \n    \n    \n    \n   \n\nPrincipal Shareholder: \n    \n    \n    \n   \n\nCuprina Holding Pte. Ltd.(4) \n -  \n 14,085,000  \n 65.7  \n 95.0 \n\n \n\n*\n\nExcept\nas otherwise indicated below, the business address of our director and executive officers is c/o Blk 1090 Lower Delta Road #06-08\nSingapore 169201.\n\n \n \n\n**\nFor\neach person and group included in this column, percentage ownership is calculated by dividing the number of shares beneficially owned\nby such person or group by the sum of the total number of shares outstanding. The total number of ordinary shares outstanding as\nof the date of this Annual Report is 21,450,000.   \n\n \n \n\n****\nFor\neach person and group included in this column, percentage of voting power is calculated by dividing the voting power beneficially\nowned by such person or group by the voting power of all of our Class A and Class B Ordinary Shares as a single class. Each holder\nof Class B Ordinary Shares is entitled to ten votes   per share, subject to certain conditions, and each holder of our\nClass A Ordinary Shares is entitled to one vote per share on all matters submitted to them for a vote. Our Class A Ordinary Shares\nand Class B Ordinary Shares vote together as a single class on all matters submitted to a vote of our shareholders, except as may\notherwise be required by law. Our Class B Ordinary Shares are convertible at any time by the holder thereof into Class A Ordinary\nShares on a one-for-one basis.\n\n \n \n\n(1)\nMr.\nQuek owns 22.2% of Cuprina Holding Pte. Ltd. As such, Mr. Quek is deemed to beneficially own 14.6% of our Company through Cuprina\nHolding Pte. Ltd.\n\n \n \n\n(2)\nMr.\nTeo owns 41.3% of Cuprina Holding Pte. Ltd. As such, Mr. Teo Peng Kwang is deemed to beneficially own 27.1% of our Company through\nCuprina Holding Pte. Ltd.\n\n \n \n\n(3)\nMr.\nLee owns 36.5% of Cuprina Holding Pte. Ltd. As such, Mr. Jimmy Lee Peng Siew is deemed to beneficially own 24.0% of our Company through\nCuprina Holding Pte. Ltd.\n\n \n \n\n(4)\nCuprina\nHolding Pte. Ltd. owns 14,085,000 Class B Ordinary Shares directly of the outstanding shares of our Company.\n\n \n\n**F.\nDisclosure of a registrant’s action to recover erroneously awarded compensation.**\n\n \n\nNot\napplicable.\n\n \n\n103"}